These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1429522)

  • 41. Purification of recombinant human cPLA2 gamma and identification of C-terminal farnesylation, proteolytic processing, and carboxymethylation by MALDI-TOF-TOF analysis.
    Jenkins CM; Han X; Yang J; Mancuso DJ; Sims HF; Muslin AJ; Gross RW
    Biochemistry; 2003 Oct; 42(40):11798-807. PubMed ID: 14529291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Correlation of antitumor effect of recombinant sea snake basic phospholipase A2 to its enzymatic activity].
    Liang YJ; Yang XP; Wei JW; Fu LW; Jiang XY; Chen SW; Yang WL
    Ai Zheng; 2005 Dec; 24(12):1474-8. PubMed ID: 16351795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cloning and expression of the gene encoding phospholipase A1 from Serratia sp. MK1 in Escherichia coli.
    Song JK; Kim MK; Rhee JS
    J Biotechnol; 1999 Jun; 72(1-2):103-14. PubMed ID: 10406101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification, characterization and gene cloning of a novel phospholipase A2 from the venom of Agkistrodon blomhoffii ussurensis.
    Bao Y; Bu P; Jin L; Hongxia W; Yang Q; An L
    Int J Biochem Cell Biol; 2005 Mar; 37(3):558-65. PubMed ID: 15618013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phospholipase A2 engineering: design, synthesis, and expression of a gene for bovine (pro)phospholipase A2.
    Noel JP; Tsai MD
    J Cell Biochem; 1989 Jul; 40(3):309-20. PubMed ID: 2674160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of type I and type II phospholipase A2 by phosphatidyl-ethanolamine linked to polymeric carriers.
    Dan P; Dagan A; Krimsky M; Pruzanski W; Vadas P; Yedgar S
    Biochemistry; 1998 Apr; 37(17):6199-204. PubMed ID: 9558359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping structural determinants of biological activities in snake venom phospholipases A2 by sequence analysis and site directed mutagenesis.
    Chioato L; Ward RJ
    Toxicon; 2003 Dec; 42(8):869-83. PubMed ID: 15019488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Native and recombinant phospholipases A
    Krayem N; Abdelkefi-Koubaa Z; Marrakchi N; Gargouri Y; Luis J
    Int J Biol Macromol; 2018 Sep; 116():305-315. PubMed ID: 29715557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human group-V phospholipase-A2 expression in Pichia pastoris and its role in eicosanoid generation.
    Lefkowitz LJ; Shinohara H; Dennis EA
    Ernst Schering Res Found Workshop; 2000; (31):25-52. PubMed ID: 10943326
    [No Abstract]   [Full Text] [Related]  

  • 50. Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin.
    Mantile G; Miele L; Cordella-Miele E; Singh G; Katyal SL; Mukherjee AB
    J Biol Chem; 1993 Sep; 268(27):20343-51. PubMed ID: 8104186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and characterization of human recombinant protein 1/Clara cell M(r) 10,000 protein.
    Okutani R; Itoh Y; Yamada T; Yamaguchi T; Singh G; Yagisawa H; Kawai T
    Eur J Clin Chem Clin Biochem; 1996 Sep; 34(9):691-6. PubMed ID: 8891520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mobilization and function of extracellular phospholipase A2 in inflammation.
    Weiss J; Wright G
    Adv Exp Med Biol; 1990; 275():103-13. PubMed ID: 2239442
    [No Abstract]   [Full Text] [Related]  

  • 53. Improvement in the heterogeneous N-termini and the defective N-glycosylation of human interleukin-6 by genetic engineering.
    Hasegawa M; Orita T; Kojima T; Tomonoh K; Hirata Y; Ochi N
    Eur J Biochem; 1992 Nov; 210(1):9-12. PubMed ID: 1446688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amino acid residues in alpha-helix-3 of human uteroglobin are critical for its phospholipase A2 inhibitory activity.
    Chowdhury B; Mantile-Selvaggi G; Kundu GC; Miele L; Cordella-Miele E; Zhang Z; Mukherjee AB
    Ann N Y Acad Sci; 2000; 923():307-11. PubMed ID: 11193767
    [No Abstract]   [Full Text] [Related]  

  • 55. Synovial phospholipase A2 serum levels in pregnancy and preeclampsia.
    Tempfer C; Hefler L; Zeisler H; Schatten C; Husslein P; Kainz C
    Acta Obstet Gynecol Scand; 2001 Jan; 80(1):27-9. PubMed ID: 11167184
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression, purification and biochemical characterization of the N-terminal regions of human TIG3 and HRASLS3 proteins.
    Han BG; Cho JW; Cho YD; Kim SY; Yoon HJ; Song HK; Cheong HK; Jeon YH; Lee DK; Lee S; Lee BI
    Protein Expr Purif; 2010 May; 71(1):103-7. PubMed ID: 20100577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic application of natural inhibitors against snake venom phospholipase A(2).
    Perumal Samy R; Gopalakrishnakone P; Chow VT
    Bioinformation; 2012; 8(1):48-57. PubMed ID: 22359435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.
    Avoranta T; Sundström J; Korkeila E; Syrjänen K; Pyrhönen S; Laine J
    Virchows Arch; 2010 Dec; 457(6):659-67. PubMed ID: 20938784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.
    Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Kallajoki M; Nevalainen TJ
    Gut; 1997 Jan; 40(1):95-101. PubMed ID: 9155583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants.
    Di Marco S; Märki F; Hofstetter H; Schmitz A; van Oostrum J; Grütter MG
    J Biochem; 1992 Sep; 112(3):350-4. PubMed ID: 1429522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.